国家重点研发计划精准医学专项—罕见病临床队列研究 

国家重点研发计划公共安全风险防控与应急技术装备重点专项——重型及危重型新型冠状病毒肺炎标准化临床数据库建立及治疗方案真实世界研究

国家自然基金委面上项目—肠道菌群结构特征与冠心病亚型关联研究

1. Orphan drug development in china: progress and challenges. The Lancet, 394(10204), 1127-1128.
   
2. Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir. 10.1101/2020.04.08.032763. 
3. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med, 2020, 382(17): 0-e38
4. Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak. European Heart Journal (2020)
5. Alterations in the gut microbiome and metabolism with coronary artery disease severity.Microbiome, 2019, 7(1).
6. Antiphospholipid Antibodies in Critically Ill PatientsWith COVID-19.Arthritis Rheumatol,2020.
7. Structural basis for inhibition of the SARS-CoV-2 RNApolymerase by suramin.Nature Structural & Molecular Biology,2021.